Evaluation of the Long Term Efficacy of Endovascular Treatment of Type 2 Endoleaks

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04409717

Enrollment

Registered

2020-06-01

Start date

2020-01-01

Completion date

2020-05-26

Last updated

2020-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Aortic Aneurysm

Brief summary

Endovascular treatment has become the first choice to repair abdominal aortic aneurym, but exposes patients to a risk of endoleaks. Although treatment of type 1 and 3 endoleaks has proven to prevent aneurysms from rupture, controversies remain about type 2 endoleaks. The investigators described the different techniques of type 2 endovascular repair, and their efficacy at short and long term..

Interventions

PROCEDUREType II endoleak treatment

Type II endoleak endovascular treatment

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 99 Years

Healthy volunteers

Inclusion criteria

* All patients treated for type II endoleaks by endovascular therapy

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame
Recurrence rate of type II endoleaks treated with endovascular intervention	12 years

Secondary

Measure	Time frame
Type of type II endoleaks treatment	12 years

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026